Tonix Pharmaceuticals Holding Corp. (TNXP)

TNXP Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7.05	24.95	120.23	178.66	77.31	11.35
Cash & Cash Equivalents	7.05	24.95	120.23	178.66	77.31	11.35
Cash Growth	-90.21%	-79.25%	-32.71%	131.10%	581.19%	-54.85%
Inventory	12.35	13.64	0	0	0	0
Other Current Assets	10.7	9.18	10.55	10.39	10.68	2.6
Total Current Assets	30.1	47.77	130.78	189.05	87.99	13.95
Property, Plant & Equipment	93.82	94.85	94.53	51.47	9.83	0.39
Goodwill and Intangibles	10.47	10.71	0.12	0	0.12	0.12
Other Long-Term Assets	0.96	1.13	0.26	0.38	0.25	0.1
Total Long-Term Assets	105.25	106.69	94.91	51.85	10.19	0.61
Total Assets	135.34	154.46	225.69	240.9	98.18	14.56
Accounts Payable	6.65	3.78	8.07	13.28	4.6	3.07
Current Debt	3.1	2.62	0.43	0.49	0.6	0.35
Other Current Liabilities	10.73	12.48	9.68	7.95	4.63	1.71
Total Current Liabilities	20.48	18.88	18.18	21.72	9.82	5.14
Long-Term Debt	6.72	7.19	0.33	0.47	0.72	0.01
Other Long-Term Liabilities	0	22.86	0	0	0	0
Total Long-Term Liabilities	6.72	30.05	0.33	0.47	0.72	0.01
Total Liabilities	27.2	48.93	18.51	22.18	10.54	5.14
Total Debt	9.82	9.81	0.76	0.96	1.31	0.36
Debt Growth	856.92%	1191.18%	-20.50%	-27.08%	266.20%	-
Retained Earnings	-615.6	-600.66	-470.04	-359.82	-267.53	-217.07
Comprehensive Income	-0.24	-0.23	-0.17	-0.09	-0.06	-0.05
Shareholders' Equity	108.14	105.53	207.18	218.72	87.65	9.42
Net Cash / Debt	-2.77	15.14	119.47	177.7	76	10.99
Net Cash / Debt Growth	-	-87.33%	-32.77%	133.83%	591.45%	-56.27%
Net Cash Per Share	-1.10	28.42	654.46	3121.06	5141.88	43788.84
Working Capital	9.62	28.88	112.6	167.33	78.17	8.81
Book Value Per Share	42.79	198.18	1134.96	3841.42	5930.19	37467.32

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).